Respiratory Morbidity Among Children Who Were Born by Elective Cesarean Section After 37-38 Weeks vs. 39 Weeks and More
NCT ID: NCT02060994
Last Updated: 2014-05-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
123 participants
OBSERVATIONAL
2014-02-28
2014-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Goal: The aim of the current study is to find out if these respiratory complications extend to later life.
Methode: Reviewing the patients' medical file, and collecting data about respiratory complication.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Respiratory Rate After Cesarean Delivery
NCT04250233
Vaginal Birth After Caesarean Section - Effect on Maternal Psychosocial Function
NCT00294411
Maternal Postop Temperature After Cesarean Delivery
NCT05661136
The Effect of Primary Cesarean Section Prevention on Maternal and Neonatal Outcomes
NCT03640702
Vaginal Birth After Caesarean Section - Effect on Maternal Psychosocial Function
NCT00517140
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Goal: The aim of the current study is to find out if these respiratory complications extend to later life.
Method: Reviewing the patients' medical file, and collecting data about respiratory complication. We will use the same patients we used at the first study. Respiratory complications are defined as diagnosis of asthma, treatment by inhalations or systemic steroids, or consultation by pulmonologist.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
37-38 weeks
Children who were born by elective Cesarean section after 37-38 gestational weeks.
Intervention: No intervention.
No intervention
No intervention
39 week or more
Children who were born by elective Cesarean section after 39 gestational weeks or more Intervention: No intervention.
No intervention
No intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
No intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
4 Years
8 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hillel Yaffe Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Erez Nadir, MD
Neonatologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Erez Nadir, MD
Role: PRINCIPAL_INVESTIGATOR
Hillle Yaffe medical center, Hadera, Israel
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hillel Yaffe medical center
Hadera, North, Israel
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Nir V, Nadir E, Feldman M. Late better than early elective term Cesarean section. Acta Paediatr. 2012 Oct;101(10):1054-7. doi: 10.1111/j.1651-2227.2012.02772.x. Epub 2012 Jul 16.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HYMC-0088-13-CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.